Experimental cancer drug study halted early

NCT ID NCT04106492

Terminated Disease control Sponsor: Shasqi, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental drug called SQ3370 in 53 people with advanced solid tumors that had spread or could not be removed by surgery. The goal was to check the drug's safety and find the best dose, as well as see if it could shrink tumors. The study was terminated early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOFT TISSUE SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Head and Neck Neoplasms head and neck squamous cell carcinoma lung neoplasm neoplasm ovarian cancer sarcoma soft tissue sarcoma uterine cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Cancer Research Institute

Adelaide, South Australia, 5000, Australia
Chris O'Brien Lifehouse

Camperdown, New South Wales, 2050, Australia
City of Hope

Duarte, California, 91010, United States
MD Anderson Cancer Center

Houston, Texas, 77030, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
Royal North Shore Hospital

Sydney, New South Wales, 2065, Australia
Sarcoma Oncology Center

Santa Monica, California, 90403, United States
Stanford Cancer Center

Palo Alto, California, 94304, United States
University of Washington

Seattle, Washington, 98195, United States
Washington University in St. Louis

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.